Navigation Links
Bristol-Myers Squibb to Announce Results for the Fourth Quarter and Full Year of 2007 on January 31
Date:1/16/2008

NEW YORK, Jan. 16 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY) will announce results for the fourth quarter and full year of 2007 on Thursday, January 31. During a 10 a.m. (ET) conference call on Jan. 31, company executives will review financial information and will address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the call at http://www.bms.com/ir or by dialing 913-312-0980. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 2 p.m. (ET) on January 31 through midnight (ET) on February 14. The replay will be available through http://www.bms.com/ir or by dialing 402-280-9013 (access code 6761149).

Bristol-Myers Squibb is a global biopharmaceutical and related health care products company whose mission is to extend and enhance human life.


'/>"/>
SOURCE Bristol-Myers Squibb Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Exelixis Submits XL139 Diligence Report to Bristol-Myers Squibb
2. EDS Awarded $715 Million Contract for Bristol-Myers Squibb Information Services
3. Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community
4. Bristol-Myers Squibb and Pierre Fabre Provide Update On Vinflunine Development Status
5. Aureus Pharma Announces Renewal and Expansion of Licensing Agreement With Bristol-Myers Squibb for its AurSCOPE Knowledge Databases
6. Bristol-Myers Squibb to Acquire Adnexus Therapeutics
7. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
8. GeneGo Enters Multi-Year Agreement With Bristol Myers Squibb for Access to GeneGo Software Suite and Databases
9. RSB Spine, LLC Announces First Implantation of the InterPlate(TM) L for the Lumbar Spine
10. Stereotaxis Announces FDA Approval of Its Partnered Magnetic Irrigated Catheter
11. Healthcare Technologies Ltd. (NASDAQ: HCTL) Announces Extension of Letters of Intent to Acquire Majority Interest in Two Ethanol Plants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... According to Jeff Howell, Partner of ... Global, new development in Downtown Toronto is expanding at ... another 755 storeys of new development last week (including ... be dominating the Toronto skyline for the foreseeable future ... thirst for new development. , As the Toronto city ...
(Date:9/15/2014)... 2014 Cancer Immunotherapy Market ... T-cell Therapies is a new market research report ... three principal types of therapeutics that have become ... cancer immunotherapy (which is often called "immuno-oncology") in ... Adoptive cellular immunotherapy. , The regular use ...
(Date:9/15/2014)... a patient has sepsis, a life-threatening condition in which ... often too fast for antibiotics to help. A new ... a team at Harvard,s Wyss Institute for Biologically Inspired ... , "Even with the best current treatments, sepsis ... 30 percent of the time," said Mike Super, Ph.D., ...
(Date:9/15/2014)... 15, 2014 Zymo Research Corp., has announced ... for safe ambient temperature storage and transport of ... infectivity of agents in such samples is completely ... of the viral nucleic acids for subsequent analyses.  ... epidemic in West Africa ...
Breaking Biology Technology:ITRA Global Reports Downtown Toronto Real Estate Development is in High Gear 2ITRA Global Reports Downtown Toronto Real Estate Development is in High Gear 3Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 2Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 3Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 4Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 5Blood-cleansing biospleen device developed for sepsis therapy 2Blood-cleansing biospleen device developed for sepsis therapy 3Blood-cleansing biospleen device developed for sepsis therapy 4Safe storage and transport of Ebola, Mers-CoV, and other viruses: Groundbreaking viral inactivation solution capable of preserving nucleic acids 2Safe storage and transport of Ebola, Mers-CoV, and other viruses: Groundbreaking viral inactivation solution capable of preserving nucleic acids 3
... the world,s leading peer-reviewed research journal, is partnering with Applied Biosystems, ... Advances in Cancer Genomics to be broadcast live online at 12 ... ... (PRWEB) April 15, 2009 -- The business office of Science, the ...
... Technologies, Inc., a leader in adult stem cell research and manufacturing, ... Scientific Advisory Board. In this capacity, she will help Stemedica ... cellular delivery system for burn and wound management. , ... ...
... EAST RUTHERFORD, N.J., April 14 Cambrex Corporation (NYSE: ... notified by the New York Stock Exchange (the "NYSE") that ... the Company,s total market capitalization and its stockholders, equity. ... the NYSE that it did not meet its continued listing ...
Cached Biology Technology:Science Magazine to Host Webinar on Advances in Cancer Genomics 2Science Magazine to Host Webinar on Advances in Cancer Genomics 3Stemedica Signs Scientific Advisory Board Agreement with Leading Pediatric Burn & Wound Care Researcher 2Stemedica Signs Scientific Advisory Board Agreement with Leading Pediatric Burn & Wound Care Researcher 3Stemedica Signs Scientific Advisory Board Agreement with Leading Pediatric Burn & Wound Care Researcher 4Cambrex Receives Notice Regarding NYSE Listing 2Cambrex Receives Notice Regarding NYSE Listing 3
(Date:9/15/2014)... CAMBRIDGE, Mass. (September 15, 2014) The so-called ... which makes proteinhas long provided a simplified explanation ... in living organisms. , In reality, of ... the schema first articulated nearly 60 years ago ... DNA,s double-helix structure. For one, there are multiple ...
(Date:9/15/2014)... Reproductive cell division has evolved a simple, mechanical ... in the Sept. 11 Science Express. ... chromosome counts and misalignments that lead to infertility, ... reproductive cell division cause these problems, but what ... Adele Marston of the Wellcome Trust Center for ...
(Date:9/15/2014)... of microorganisms may be responsible for much of the ... for the global carbon cycle and climate change. , ... most life on this planet, it is only produced ... is so large and complex. For humans, vitamin B12 ... nervous systems, as well as DNA synthesis in cells ...
Breaking Biology News(10 mins):Scientists discover RNA modifications in some unexpected places 2Cells simply avoid chromosome confusion 2Cells simply avoid chromosome confusion 3Researchers discover new producer of crucial vitamin 2
... key influence on a child,s ability to deal with stress. ... an important role in changing the impact of genes that ... , That,s the message from a new study by ... University, the University of North Carolina-Greensboro, and North Carolina State ...
... than 125 years ago Charles Darwin first reported that most ... day and this week, scientists are reporting the discovery ... growth spurts, and the ability of plants to move in ... circadian rhythms the "biological clock" genes that are influenced ...
... of researchers headed by biologists at Washington University in St. ... manages two disparate operations photosynthesis and nitrogen fixation ... Himadri B. Pakrasi, Ph.D., George William and Irene Koechig ... the genome of Cyanothece sp. ATCC 51142 to ...
Cached Biology News:Early parenting plays key role in infants' physiological response to stress 2'Biological clock' genes control plant growth 2Cyanobacterium sequenced features rare linear chromosome 2Cyanobacterium sequenced features rare linear chromosome 3